The European School of Multimodality Imaging & Therapy (ESMIT)

Introducing Dosimetry in the Clinical Setting
2025-05-09 13:30 - 14:30 (Europe/Vienna)
This course presents and discusses the requirements and methods to enable and perform personalized dosimetry in nuclear medicine therapy.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

The aim of this course is to provide tools and methods to implement personalized dosimetry in a clinical setup.

Target Audience

Nuclear medicine clinicians and medical physicists

Suggested Readings

“EANM enabling guide: how to improve the accessibility of clinical dosimetry.” Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry

Click Here

Faculty

Jonathan GearSpeaker

Pablo Mínguez GabiñaSpeaker

Eivor HernesSpeaker

Silvano GnesinModerator

Event Overview

Cardiac Amyloidosis Imaging: Do We Need Quantification?
2025-06-13 13:30 - 14:30
This webinar provides an overview of the diagnosis of cardiac amyloidosis in nuclear cardiology . Background information on amyloidosis in general is presented and typical disease manifestations are discussed. Furthermore, the significance of cardiac amyloidosis will be discussed in detail and possible therapeutic options will be explained. In this context, the relevance of quantification to characterize disease and how to assess reliably the effects of therapy are presented.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

To gain a insight into the disease of amyloidosis and in particular the cardiac involvement of amyloidosis.

To learn the possibilities of quantification of planar and SPECT studies in amyloidosis

Target Audience

Nuclear physicians, cardiologists, internists and radiologists who are interested in amyloidosis and want to deepen their knowledge of cardiac amyloidosis diagnostics and quantification

Faculty

Federico CaobelliSpeaker

Ian ArmstrongSpeaker

Carmela NappiModerator

Stephan NekollaModerator

Event Overview

Extravascular Administration in Diagnostic and Therapeutic Nuclear Medicine
2025-06-27 13:30 - 14:30
In nuclear medicine, diagnostic as well as therapeutic, radiopharmaceuticals are administered via an intravenous injection, in a majority of the procedures in a blood vessel at the crook of the arm or on the back of the hand. Occasionally, the injection fails, which results in the radiopharmaceutical ending up extravascularly. The consequence of this may be a locally high radiation dose at the injection site, in some situations high enough to cause severe tissue effects on the patient. Thus, it is important to recognize the problem and identify the cause in order to decrease the risk. Furthermore, the management of the situation after such an extravasation must be dealt with thoroughly and this has been the subject of lively debate in recent years. The parameters that have an impact on the radiation dose are among other things, the physical properties of the radionuclide, as well as the activity and volume of the radioactive substance retained in the surroundings of the blood vessel. In the case when most of the administered activity ends up extravascular, the quality of the diagnostic procedure or the effect of the treatment are negatively affected, which must be addressed.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

The aim of this webinar is to highlight the risk and consequences of extravascular administration of radiopharmaceuticals as well as the management of the situation after an extravasation.

Target Audience

Physicists, Physicians, Technologists, Nurses

Faculty

Siria MediciSpeaker

Jochem van der Pol Speaker

Sigrid Leide SvegbornModerator

Event Overview

Alpha Emitters – The Roadmap of the Big Ones!
2025-07-04 13:30 - 14:30
The purpose of this seminar is to provide a comprehensive overview of radionuclide therapy using alpha-emitting isotopes, focusing on their current clinical and preclinical applications. It will explore the unique advantages of alpha emitters, such as their high linear energy transfer and short path length, which allow for precise tumor cell killing with minimal damage to surrounding tissue. The seminar will also address key challenges, including limited availability of suitable alpha-emitting radionuclides, complex radiochemistry, and safety concerns during production and handling. Emphasis will be placed on production routes, chelation strategies, and conjugation chemistry that enable targeted delivery to cancer cells. Finally, the session will critically evaluate the therapeutic potential and limitations of alpha therapy, highlighting areas for future research and clinical translation.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

Participants will gain understanding of the advantages of alpha-emitters over beta emitter

Participants will be able to describe and explain challenges arising from applications of alpha-emitters

Target Audience

Radiochemist, Radiopharmacists, nuclear physicians with a research profile, medicinal chemistry researchers

Faculty

Matthias HerthSpeaker

Filipe ElvasSpeaker

Dana NiculaeModerator

Event Overview

Technical Aspects of Parenteral Administration of Radiopharmaceuticals to Oncological Patients
2025-08-29 13:30 - 14:30
For performing the PET/CT examination, the administration of radiopharmaceutical as unavoidable for imaging with PET. Inversely, the administration of contrast agent to improve the quality of CT part of PET/CT as optional. The accurate intravenous administration of diagnostic radiopharmaceutical (and optionally of contrast agent) may be challenging in some cases, in particular in patients with compromised peripheral venous access after several lines of treatments. In order to increase the patient comfort and to simplify the intravenous administration of medicines, several types of long-term venous access have been developed.

Register nowEnrol in the live webinar now for free! Register now!

Learning Objectives

To understand the different types of currently available long-term venous accesses

To understand the principles of safe and correct handling of long-term venous access in patient referred for PET/CT

Target Audience

Nuclear Medicine Professionals

Faculty

Eugenia TrigosoSpeaker

Sona BalogovaSpeaker

Conrad-Amadeus VoltinModerator

Event Overview

Radiation Safety for Oncological Patients before and after Nuclear Medicine Procedures and Radiation Safety of Nursing Staff
2025-09-19 13:30 - 14:30
This webinar will emphasize the critical importance of radiation protection in safeguarding both the occupational health of care providers and the well-being of patients undergoing radionuclide therapy.

It will underscore the necessity of adhering to established guidelines and protocols when handling radioactive materials to ensure safety and treatment efficacy.

Furthermore, the session will explore the role of interprofessional collaboration and continuing education among health care providers in enhancing radiation safety practices. It will also present evidence-based strategies to mitigate patients’ symptoms associated with the adverse effects of radionuclide treatment.

Register now!Enrol in the live webinar now for free! Register now

Learning Objectives

To identify the primary steps for introducing newly hired health care staff to radionuclide therapy protocols and recognize the importance of continuous education in maintaining adherence to institutional safety and procedural standards.

To evaluate various educational methods and strategies used to train health care providers—including nurses, caregivers, seasonal workers, and clinical assistants—in the principles, procedures, and safety protocols of radionuclide therapy.

To demonstrate effective patient education techniques and symptom management strategies for individuals undergoing radionuclide therapy, with attention to minimizing adverse effects and enhancing patient comprehension.

To compare different radiation safety protocols and clinical guidelines associated with Lutathera and radioiodine therapies, with respect to implications for both patients and health care providers.

Target Audience

All health care providers involved in the care of oncological patients undergoing radionuclide treatment in clinical practice

Faculty

Lace MatarloSpeaker

Matthias Hellberg-NaegeleModerator

Sigrid Leide SvegbornSpeaker

Explainable AI
2025-10-24 13:30 - 14:30
The webinar will provide first the fundamentals and basics of explainable artificial intelligence, including the tools for interpretability of machine and deep learning models, as well as the explainability principles. Second, it will provide how these concepts are translated and applied to the development of AI-based models for nuclear medicine applications.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

Attendees will be able to understand what are the concepts and methods that define explainable AI, including interpretability tools and algorithms, as well as explainability concepts to translate these to the end-users.

Attendees will be able to discover how these concepts can be used to facilitate the development, adoption and trust for end-users of AI-based models in nuclear medicine applications.

Target Audience

Nuclear medicine physicians, scientists and technologists interested in the application of artificial intelligence in nuclear medicine imaging applications.

Faculty

Neo Christopher ChungSpeaker

Clemens SpielvogelSpeaker

Mathieu HattModerator

Event Overview

Nuclear Medicine-related Highlights from ESMO 2025
2025-11-07 13:30 - 14:30
This ESMO 2025 webinar will cover a range of topics, including the latest advancements treatment options, imaging modalities and performant tracers related to solid and liquid tumors. The focus of this Live event will be the recent advances in solid & liquid tumor treatment, clinical trials and emerging therapies, biomarkers in solid tumors and multidisciplinary approaches. The importance of collaboration among medical oncologists, radiologists, nuclear medicine physicians, pathologists and surgeons will be underlined, based on clinical examples. Challenges and opportunities in immunotherapy for solid tumors will also be addressed, with special attention for personalized treatment plans in specific cancers, like lung cancer, breast cancer, colorectal and prostate cancer.

Please note that the webinar will be recorded, and the recording will be available a few days after the session is over. You can find the recording on the ESMIT E-learning platform, under the webinar title. A handout of the presentation materials will also be available on the platform.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

Attendees will get insight into recent advances in solid/ liquid tumor treatment

Attendees will be familiarized with the latest developments when diagnosing, staging and treating different types of solid and liquid tumors.

Target Audience

Fellows and Medical Specialists in Nuclear Medicine, Radiology, Medical Oncology, Urology, Surgery, Pathology and Radiation Oncology

Faculty

David KerstingModerator

Karolien GoffinSpeaker

Matthias EiberSpeaker

Event Overview

Paediatric Thyroid Cancer
2025-11-14 13:30 - 14:30
This webinar aims to underly the most relevant differences with the adults DCT regarding epidemiology, genetics, pathology, immunoistopathology, diagnostic tools and treatment, especially for RAI theranostic procedure. Additionally, the webinar will also go over the main GL recommendations, as well as present and discuss two emblematic or tricky cases.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

The aim of this course is to sensitise the attendees about the correct way to recognise, diagnose and treat DTC in children.

Target Audience

Physicians, residents with special interest on endocrinlogy and endo-oncology, nuclear medicine specialists, nurses and technicians of nuclear medicine units.

Suggested Readings

Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S; American Thyroid Association Guidelines Task Force. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015 Jul;25(7):716-59. doi: 10.1089/thy.2014.0460. PMID: 25900731; PMCID: PMC4854274.

Lebbink CA, Links TP, Czarniecka A, Dias RP, Elisei R, Izatt L, Krude H, Lorenz K, Luster M, Newbold K, Piccardo A, Sobrinho-Simões M, Takano T, Paul van Trotsenburg AS, Verburg FA, van Santen HM. 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma. Eur Thyroid J. 2022 Nov 29;11(6):e220146. doi: 10.1530/ETJ-22-0146. PMID: 36228315; PMCID: PMC9716393.

Czarniecka A, Woźniak G, Kropińska A, Jarząb B, Handkiewicz-Junak D. Surgical approach to differentiated thyroid cancers (DTC) in children [Specyfika leczenia chirurgicznego zróżnicowanych raków tarczycy (ZRT) u dzieci]. Endokrynol Pol. 2019;70(4):357-366. doi: 10.5603/EP.a2019.0033. PMID: 31489960.

Faculty

Desiree DeandreisSpeaker

Catia OliantiModerator

Livia LamartinaSpeaker

Event Overview

Japanese vs. European View on Targeted Radionuclide Therapy
2025-12-01 10:00 - 11:00
This event is a collaboration between ESMIT and JSNM. The aim of the webinar is to compare the approach to targeted radionuclide therapy (TRT) in Japan and in Europe. The webinar will focus on the differences in the TRT environment in Japan vs. Europe, including regulatory science and radiation protection regulation, and more.

Register nowEnrol in the live webinar now for free! Register now

Target Audience

Nuclear Medicine Physicians

Faculty

Tatsuya HigashiSpeaker

Wolfgang FendlerSpeaker

Conrad-Amadeus VoltinModerator

Event Overview

To AI or not to AI in Neurology: That is the Question
2025-12-12 13:30 - 14:30
This webinar will explore state-of-the-art AI approaches for advancing neuroimaging, with a particular focus on quantitative PET. It will cover the entire imaging pipeline, from preprocessing, acquisition, and tomographic reconstruction to quantification, segmentation, denoising, and resolution enhancement, demonstrating how modern AI can enable more reproducible and robust brain PET biomarkers. Through two expert presentations and practical case examples, the webinar will showcase how AI-driven methodologies are reshaping neuroimaging research and supporting more accurate diagnosis and disease monitoring.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

Learn the principles behind AI-based quantitative PET methods

Understand how AI can enhance each stage of the neuroimaging pipeline, from preprocessing and reconstruction to segmentation, denoising, and resolution recovery.

Critically assess when AI meaningfully improves neuroimaging workflows

Recognize emerging opportunities and challenges in integrating AI tools into brain PET

Target Audience

Nuclear physicians, medical physicists, imaging scientists and radiologists working in PET neuroimaging

Faculty

Pablo Aguilar FernándezModerator

Dimitris VisvikisSpeaker

Charalampos TsoumpasSpeaker

Event Overview

Innovations in Theranostics for Neuroblastoma
2026-02-06 13:30 - 14:30
This course provides a comprehensive update on instrumental and radiopharmaceutical innovations in the diagnosis and treatment of neuroblastoma. Participants will explore current and emerging imaging modalities, with a comparative analysis of MIBG, MFBF, FDOPA, and Gallium-based tracers, highlighting their evolving roles in staging, risk stratification, and response assessment.

The course will address recent changes in clinical practice and the challenges these advancements pose for pediatric oncologists and nuclear medicine physicians, emphasizing multidisciplinary decision-making.

In addition, the program will review novel therapeutic strategies for refractory and relapsed neuroblastoma, with a focus on radioligand therapy and its integration with immunotherapy approaches, including CAR-T cell therapy. Through state-of-the-art updates and clinical perspectives, the course aims to equip clinicians with practical insights for optimizing diagnostic accuracy and therapeutic outcomes in this complex pediatric malignancy.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

Describe recent instrumental and radiopharmaceutical innovations in the diagnosis and management of neuroblastoma.

Compare the clinical indications, advantages, and limitations of MIBG, MFBF, FDOPA, and Gallium-based imaging tracers in neuroblastoma.

Evaluate how emerging imaging techniques are changing staging, risk stratification, and treatment response assessment in pediatric patients.

Identify current challenges and unmet needs faced by pediatric oncologists and nuclear medicine physicians in integrating new diagnostic tools into clinical practice.

Discuss the principles and clinical applications of radioligand therapy in refractory and relapsed neuroblastoma.

Assess the potential role of combined treatment strategies, including radioligand therapy with immunotherapy and CAR-T cell therapy, in improving patient outcomes.

Apply multidisciplinary decision-making approaches to optimize personalized diagnostic and therapeutic strategies for children with neuroblastoma.

Target Audience

Nuclear Medicine Physicians

Suggested Reading

Se Whee Sammy Park et al. Front Oncol 14:1408729. doi: 10.3389/fonc.2024.1408729 , Lise Borgwardt et al, The Journal of Nuclear Medicine (2024). DOI: 10.2967/jnumed.123.267256

Faculty

Julian RogaschSpeaker

Bart de KeizerSpeaker

Marie LuporsiModerator

Event Overview

Beyond Single Modality: The Future of Cancer Staging with Hybrid Scanners
2026-02-20 13:30 - 14:30
This webinar will be on the future of cancer staging with hybrid imaging technologies. Participants will gain an overview of advanced PET/CT, SPECT/CT, and PET/MRI systems, learning how hybrid imaging enhances diagnostic accuracy and supports more precise clinical decisions.The session will explore the practical challenges technologists face when working with these cutting-edge systems, including image acquisition, processing, and interpretation, while highlighting the technical skills needed for effective operation.We’ll also discuss educational gaps and training opportunities for radiographers and technologists, presenting strategies such as hands-on workshops, e-learning, and mentorship to support professional development.By the end of this webinar, attendees will have a clear understanding of the evolving role of technologists in hybrid oncological imaging and be inspired to embrace innovation, lifelong learning, and interdisciplinary collaboration.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

Describe the most advanced hybrid imaging technologies used for oncological staging in nuclear medicine Understand the key features of PET/CT, SPECT/CT, and PET/MRI systems

Distinguish the main advantages and limitations of hybrid modalities in clinical oncology

Understand the added value of multimodality imaging compared with single-modality approaches Identify cases where hybrid imaging improves sensitivity, specificity, or diagnostic accuracy Recognize how functional-anatomical integration supports more precise clinical decisions

Analyze the main challenges faced by technologists in the acquisition, processing, and interpretation of hybrid imaging data Highlight practical issues (e.g., image registration, calibration, artifacts, acquisition timing)Reflect on the technical skills required to operate hybrid systems effectively

Identify educational gaps and learning challenges encountered by radiographers/technologists when adopting new hybrid technologies Recognize organizational, infrastructural, and educational barriers (e.g., equipment availability, supervision, time constraints) Assess variations in training opportunities across European contexts

Propose strategies and training programs for integrating hybrid skills into radiotherapy technician (RTM) programs, fostering critical awareness of the evolving role of the technician in the context of hybrid oncology imaging.Suggest training models (advanced courses, internships at centers of excellence, e-learning, hands-on workshops)Outline a roadmap for continuous development (on-the-job training, certifications, mentorships)

Promote a proactive mindset toward technological innovation and self-development

Target Audience

Nuclear medicine Technologists

Faculty

Oliver RamsaySpeaker

Nia HopsonSpeaker

Paolo TurcoModerator

Event Overview

Radiobiological Aspects of PRRT
2026-03-13 13:30 - 14:30
More info will come soon

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

More info will come soon

Target Audience

More info will come soon

Faculty

SpeakerSpeaker

SpeakerSpeaker

SpeakerModerator

Event Overview

FDG PET/CT in Inflammation and Infection: from Theory to Clinical Practice!
2026-03-27 13:30 - 14:30

Open your Heart on SPECT and PET Studies: Synergistic Information from the CT
2026-04-10 13:30 - 14:30

Dosimetry in Clinical Trials
2026-05-08 13:30 - 14:30

FAP and Stroma Imaging – Current and Future Applications
2026-05-29 13:30 - 14:30

Navigating International Guidelines for the Management of Thyroid Cancer
2026-06-19 13:30 - 14:30

Auger Electron Emitters – Why Consider this Therapeutic Option?
2026-07-03 13:30 - 14:30

Trustworthy AI and Human Oversight
2026-09-18 13:30 - 14:30

With a Little Help of Artificial Intelligence for the Sake of Radiation Protection
2026-11-06 13:30 - 14:30

Ring Geometry SPECT/CT System
2026-11-27 13:30 - 14:30

Tips and Tricks on Imaging with New CZT SPECT Systems
2026-12-11 13:30 - 14:30
